Cargando…
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Cannabis and related compounds have created significant research interest as a promising therapy in many disorders. However, the individual therapeutic effects of cannabinoids and the incidence of side effects are still difficult to determine. Pharmacogenomics may provide the answers to many questio...
Autores principales: | Babayeva, Mariana, Loewy, Zvi G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137111/ https://www.ncbi.nlm.nih.gov/pubmed/37185752 http://dx.doi.org/10.3390/cimb45040228 |
Ejemplares similares
-
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020) -
Pharmacogenomics of CRC treatments: putting bricks on the path to personalized medicine
por: Fernández-Rozadilla, Ceres, et al.
Publicado: (2014) -
Pharmacogenomic Biomarkers in Neuropsychiatry: The Path to Personalized Medicine in Mental Disorders
por: Cacabelos, Ramón
Publicado: (2009) -
Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy
por: Babayeva, Mariana, et al.
Publicado: (2016) -
Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
por: Loh, Feng-Hua, et al.
Publicado: (2021)